The Chemours Company (NYSE:CC) Position Raised by Captrust Financial Advisors

Captrust Financial Advisors increased its position in shares of The Chemours Company (NYSE:CC) by 9.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,130 shares of the specialty chemicals company’s stock after purchasing an additional 1,165 shares during the period. Captrust Financial Advisors’ holdings in Chemours were worth $222,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Quadrant Capital Group LLC raised its stake in Chemours by 100.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 1,119 shares during the period. Aster Capital Management DIFC Ltd acquired a new position in shares of Chemours during the fourth quarter valued at about $48,000. Itau Unibanco Holding S.A. raised its position in shares of Chemours by 39.3% during the fourth quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company’s stock valued at $60,000 after buying an additional 1,003 shares during the last quarter. KBC Group NV raised its position in shares of Chemours by 38.2% during the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock valued at $104,000 after buying an additional 1,708 shares during the last quarter. Finally, Sterling Capital Management LLC raised its position in Chemours by 54.8% in the fourth quarter. Sterling Capital Management LLC now owns 8,453 shares of the specialty chemicals company’s stock worth $143,000 after purchasing an additional 2,991 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. UBS Group dropped their price target on shares of Chemours from $18.00 to $17.00 and set a “buy” rating for the company in a research report on Wednesday, May 7th. BMO Capital Markets reduced their price objective on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 19th. Royal Bank of Canada reduced their price objective on shares of Chemours from $17.00 to $14.00 and set an “outperform” rating on the stock in a research note on Thursday, May 8th. Mizuho set a $15.00 target price on shares of Chemours in a report on Tuesday, April 15th. Finally, Wall Street Zen lowered shares of Chemours from a “hold” rating to a “sell” rating in a report on Wednesday. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Chemours has an average rating of “Hold” and a consensus target price of $17.56.

Chemours Stock Performance

Shares of CC opened at $10.84 on Friday. The firm has a 50-day moving average of $12.05 and a 200-day moving average of $16.08. The Chemours Company has a one year low of $9.33 and a one year high of $27.31. The company has a market cap of $1.62 billion, a PE ratio of 19.02 and a beta of 1.76. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.37 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the previous year, the firm posted $0.32 EPS. The business’s quarterly revenue was up .4% on a year-over-year basis. As a group, equities analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Monday, June 16th. Shareholders of record on Monday, May 19th will be paid a $0.0875 dividend. This represents a yield of 3.17%. The ex-dividend date is Friday, May 16th. Chemours’s dividend payout ratio (DPR) is 175.00%.

Insider Activity

In related news, CFO Shane Hostetter purchased 4,450 shares of the firm’s stock in a transaction that occurred on Monday, May 19th. The shares were bought at an average cost of $11.28 per share, with a total value of $50,196.00. Following the acquisition, the chief financial officer now owns 59,694 shares of the company’s stock, valued at $673,348.32. This trade represents a 8.06% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.47% of the company’s stock.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.